Arsenic in public water supplies and cardiovascular mortality in Spain. 2010

M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Sinesio Delgado 6, 28029 Madrid, Spain.

BACKGROUND High-chronic arsenic exposure in drinking water is associated with increased cardiovascular disease risk. At low-chronic levels, as those present in Spain, evidence is scarce. In this ecological study, we evaluated the association of municipal drinking water arsenic concentrations during the period 1998-2002 with cardiovascular mortality in the population of Spain. METHODS Arsenic concentrations in drinking water were available for 1721 municipalities, covering 24.8 million people. Standardized mortality ratios (SMRs) for cardiovascular (361,750 deaths), coronary (113,000 deaths), and cerebrovascular (103,590 deaths) disease were analyzed for the period 1999-2003. Two-level hierarchical Poisson models were used to evaluate the association of municipal drinking water arsenic concentrations with mortality adjusting for social determinants, cardiovascular risk factors, diet, and water characteristics at municipal or provincial level in 651 municipalities (200,376 cardiovascular deaths) with complete covariate information. RESULTS Mean municipal drinking water arsenic concentrations ranged from <1 to 118 microg/L. Compared to the overall Spanish population, sex- and age-adjusted mortality rates for cardiovascular (SMR 1.10), coronary (SMR 1.18), and cerebrovascular (SMR 1.04) disease were increased in municipalities with arsenic concentrations in drinking water > 10 microg/L. Compared to municipalities with arsenic concentrations < 1 microg/L, fully adjusted cardiovascular mortality rates were increased by 2.2% (-0.9% to 5.5%) and 2.6% (-2.0% to 7.5%) in municipalities with arsenic concentrations between 1-10 and >10 microg/L, respectively (P-value for trend 0.032). The corresponding figures were 5.2% (0.8% to 9.8%) and 1.5% (-4.5% to 7.9%) for coronary heart disease mortality, and 0.3% (-4.1% to 4.9%) and 1.7% (-4.9% to 8.8%) for cerebrovascular disease mortality. CONCLUSIONS In this ecological study, elevated low-to-moderate arsenic concentrations in drinking water were associated with increased cardiovascular mortality at the municipal level. Prospective cohort studies with individual measures of arsenic exposure, standardized cardiovascular outcomes, and adequate adjustment for confounders are needed to confirm these ecological findings. Our study, however, reinforces the need to implement arsenic remediation treatments in water supply systems above the World Health Organization safety standard of 10 microg/L.

UI MeSH Term Description Entries
D008297 Male Males
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D004784 Environmental Monitoring The monitoring of the level of toxins, chemical pollutants, microbial contaminants, or other harmful substances in the environment (soil, air, and water), workplace, or in the bodies of people and animals present in that environment. Monitoring, Environmental,Environmental Surveillance,Surveillance, Environmental
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001151 Arsenic A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed) Arsenic-75,Arsenic 75
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
July 1968, The Journal of the Arkansas Medical Society,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
May 2010, Journal of exposure science & environmental epidemiology,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
October 1999, Bulletin of environmental contamination and toxicology,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
December 1950, Public health,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
August 1953, Journal of the Medical Association of the State of Alabama,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
June 1894, British medical journal,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
January 1977, Canadian journal of public health = Revue canadienne de sante publique,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
June 1952, Hospitals,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
May 1952, Pediatrics,
M A José Medrano, and Raquel Boix, and Roberto Pastor-Barriuso, and Margarita Palau, and Javier Damián, and Rebeca Ramis, and José Luis Del Barrio, and Ana Navas-Acien
October 1963, JAMA,
Copied contents to your clipboard!